Watch this short video highlight to hear about the latest data from CROI 2020 on weight gain and other metabolic changes during ART as well as new information on HIV prevention strategies.
Watch this short video highlight to hear about the latest data from CROI 2020 on long-acting ART options.
Watch this short video highlight to hear expert insights on the latest updates from CROI 2020 on what investigators are doing to advance strategies aimed at curing HIV infection.
Here are my picks for the most intriguing studies being presented at CROI 2020, including data on long-acting injectable ART, the cardiometabolic effects of INSTIs, and a randomized trial comparing dolutegravir vs efavirenz in pregnant women.
Data on the efficacy and safety of ART during pregnancy continue to accrue, including new information on weight gain with different regimens. How do new weight gain findings during/after pregnancy compare with the nonpregnant population, and do the implications of weight gain differ in pregnancy? Here’s my take.
Weight gain has been associated with certain ARV regimens and new data show that this may lead to metabolic complications. How will these new data affect the way in which we treat and monitor patients with HIV? Here’s my take.
Listen to downloadable audio from a live Webinar in which CCO’s expert faculty provides insights on the most clinically relevant new HIV data presented at CROI 2020 including data on long-acting ART, weight gain during ART, and HIV prevention.
Listen to downloadable audio from a live Webinar in which CCO’s expert faculty provides insights on the most clinically relevant new HIV data presented at CROI 2020 including data on long-acting ART, weight gain during ART, and HIV prevention.
Listen to downloadable audio from a live Webinar in which CCO’s expert faculty provides insights on the most clinically relevant new HIV data presented at CROI 2020 including data on long-acting ART, weight gain during ART, and HIV prevention.
In this downloadable slideset, CCO’s expert faculty members summarize key studies from this important annual conference, including new data on the following hot topics: late-phase investigational ART strategies, weight gain and metabolic outcomes during ART, outcomes with ART during pregnancy, rapid ART initiation, and others.
A long-acting injectable ART option has reached the clinic in Canada and is anticipated to soon be available in other regions of the world. How will this new option and other long-acting strategies coming down the pipeline affect clinical care of our patients with HIV, and what are the specific implications for patient and provider experience in the United Kingdom? Here’s my take.
It was impossible to miss the impact of COVID-19 on CROI 2020, but what does the emergence of this pandemic mean for our patients living with HIV? Here’s my take based on what I am seeing in Spain.
Experts review new HIV study data on long-acting treatment, switch strategies, care linkage, and coinfection management from CROI 2020 that will affect practice for international clinicians managing HIV patient care around the world.
Hear insights from Monica Gandhi, MD, MPH, on new data reported at CROI 2020 related to weight gain and other metabolic changes during HIV antiretroviral therapy (ART) as well as new information on HIV prevention strategies.
USF Health
Office of Continuing Professional Development (OCPD)
124 S. Franklin Street
Tampa, FL 33602
(800) 852-5362
(813) 224-7860
(813) 224-7864 (Fax)
cpdsupport@usf.edu
https://health.usf.edu/cpd
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.